Lv75
4690 积分 2022-09-02 加入
A UHPLC-MS/MS method for the simultaneous quantification of BTK inhibitors and their active metabolite in human plasma and cerebrospinal fluid
2天前
已关闭
Immune thrombocytopenia: Evolving mechanistic understanding and clinical development of new therapies
2天前
已完结
RCLARITY : A Prospective Phase II Study of Rituximab Combined With Lenalidomide and Chidamide ( RLC ) for the Treatment of Relapsed/Refractory Angioimmunoblastic T‐Cell Lymphoma
4天前
已完结
High-Risk Mantle Cell Lymphoma in the Era of Novel Agents
15天前
已完结
Successful treatment of pure red cell aplasia with Orelabrutinib following major ABO-incompatible hematopoietic stem cell transplantation for acute myeloid leukemia: A case report
15天前
已完结
基于美国FDA不良事件报告系统数据库的血小板生成素受体激动剂血栓栓塞和肝毒性风险信号挖掘
18天前
已完结
Ianalumab plus Eltrombopag in Immune Thrombocytopenia
20天前
已完结
A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia
20天前
已完结
Multicentre, randomised phaseIIIstudy of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia
1个月前
已完结
Outcomes with ibrutinib in patients with chronic lymphocytic leukaemia: Results from the German multicentre REALITY study
1个月前
已完结
皖公网安备34019202002308
